Amicus Therapeutics Inc (NASDAQ: FOLD) is -1.59% lower on its value in year-to-date trading and has touched a low of $8.78 and a high of $14.03 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FOLD stock was last observed hovering at around $9.21 in the last trading session, with the day’s gains setting it 0.06%.
Currently trading at $9.27, the stock is -2.59% and -6.47% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.5 million and changing 0.65% at the moment leaves the stock -11.40% off its SMA200. FOLD registered -29.67% loss for a year compared to 6-month loss of -14.48%. The firm has a 50-day simple moving average (SMA 50) of $9.9546 and a 200-day simple moving average (SMA200) of $10.4751.
The stock witnessed a -8.67% gain in the last 1 month and extending the period to 3 months gives it a -11.04%, and is -0.96% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.75% over the week and 3.67% over the month.
Amicus Therapeutics Inc (FOLD) has around 517 employees, a market worth around $2.77B and $493.67M in sales. Fwd P/E is 70.34. Profit margin for the company is -21.21%. Distance from 52-week low is 5.52% and -33.93% from its 52-week high. The company has generated returns on investments over the last 12 months (-17.02%).
The EPS is expected to grow by 61.14% this year
378.0 institutions hold shares in Amicus Therapeutics Inc (FOLD), with institutional investors hold 104.71% of the company’s shares. The shares outstanding are 298.69M, and float is at 290.29M with Short Float at 6.67%. Institutions hold 103.91% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 28.59 million shares valued at $283.6 million. The investor’s holdings represent 9.4382 of the FOLD Shares outstanding. As of 2024-06-30, the second largest holder is PERCEPTIVE ADVISORS LLC with 28.06 million shares valued at $278.33 million to account for 9.2629 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 27.4 million shares representing 9.0458 and valued at over $271.81 million, while BLACKROCK INC. holds 8.046 of the shares totaling 24.37 million with a market value of $241.77 million.
Amicus Therapeutics Inc (FOLD) Insider Activity
The most recent transaction is an insider sale by Campbell Bradley L, the company’s President and CEO. SEC filings show that Campbell Bradley L sold 7,500 shares of the company’s common stock on Dec 02 ’24 at a price of $10.02 per share for a total of $75124.0. Following the sale, the insider now owns 0.89 million shares.
Still, SEC filings show that on Nov 06 ’24, Campbell Bradley L (President and CEO) disposed off 7,901 shares at an average price of $12.50 for $98800.0. The insider now directly holds 886,654 shares of Amicus Therapeutics Inc (FOLD).
